The
urological device market is a well-established, relatively commoditized
market. However, there are a few
exceptions to this. In particular, this
report examines recent innovations that aim to bring minimally invasive
methodology, and low tissue damage procedures to benign prostatic hyperplasia
(BPH) devices. Over the forecast period,
the urology device market is expected to experience steady growth. Although a multitude of factors influence
this growth, the socio-economic factors (obesity and age) facing the U.S.
function as the dominant driver to this growth. Other major drivers for this
market are an aging population, increasing medical coverage and a changing
industry preference for high quality, single-use devices. Much of the
urological device market is well established. This limits significant changes
in average selling prices (ASP). However, recent regulations have forced
hospitals and manufacturers to be wary of the potential for contamination of
reusable units. This relation of reimbursement to infection rates is driving
the disposable, single-use market. Single-use units traditionally have a higher
per use cost, thereby driving up the overall market for many urological
segments.
The
U.S. urological market includes devices for urinary incontinence, stone
management, BPH (benign prostate hyperplasia) treatment devices, urological
endoscopes, prostate cancer, urodynamic equipment, nephrostomy and erectile
dysfunction. Although yet to be observed, an expected influencer of the
urological device market is the shift of urologists from private practice to
hospital settings. This movement has
been anticipated for the past several years; however, any shift that has
occurred to this date has been minimal. Over the forecast period, this shift is
expected to play a critical role in the urological device market.
Spanning over 55 pages “US
Market Overview for Urological Devices 2016 - MedView” report
covers Executive Summary, Research Methodology, U.S. Urological Devices Market
Overview. The report covered companies are - Boston Scientific, C. R. Bard,
Coloplast, Olympus, Medtronic, Karl Storz, Cook Medical, Astora, Laborie,
Medline, Elekta, Ethicon, Richard Wolf, Varian
For
more information Visit at: http://mrr.cm/JVv
Find all
Pharma
and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.